GSA Capital Partners’s Medline Inc MDLN Stock Holding History

GSA Capital Partners’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,902	Closed	-$374K	–	2258
2025 Q4	$374K	Buy	+8,902	New	+$376K	0.03%	1028

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

GSA Capital Partners's MDLN Position: Q1 2026 in Review

GSA Capital Partners sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 8,902 shares — an estimated $374K sold.

GSA Capital Partners first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $374K in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

GSA Capital Partners reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
GSA Capital Partners sold 8,902 Medline Inc shares in Q1 2026, an estimated $374K.
GSA Capital Partners first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
GSA Capital Partners's Medline Inc position peaked at $374K in Q4 2025.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.